<VariationArchive RecordType="classified" VariationID="802681" VariationName="NM_005609.4(PYGM):c.2075_2076del (p.Thr692fs)" VariationType="Deletion" Accession="VCV000802681" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2020-01-11" MostRecentSubmission="2020-01-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="791148" VariationID="802681">
      <GeneList>
        <Gene Symbol="PYGM" FullName="glycogen phosphorylase, muscle associated" GeneID="5837" HGNC_ID="HGNC:9726" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11q13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="64746389" stop="64760715" display_start="64746389" display_stop="64760715" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="64513860" stop="64528186" display_start="64513860" display_stop="64528186" Strand="-" />
          </Location>
          <OMIM>608455</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_005609.4(PYGM):c.2075_2076del (p.Thr692fs)</Name>
      <CanonicalSPDI>NC_000011.10:64750476:GG:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11q13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="64750477" stop="64750478" display_start="64750477" display_stop="64750478" variantLength="2" positionVCF="64750476" referenceAlleleVCF="TGG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="64517949" stop="64517950" display_start="64517949" display_stop="64517950" variantLength="2" positionVCF="64517948" referenceAlleleVCF="TGG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>T692fs</ProteinChange>
      <ProteinChange>T604fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.64750477_64750478del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.64750477_64750478del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.64517949_64517950del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.64517949_64517950del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_013018.1" sequenceAccession="NG_013018" sequenceVersion="1" change="g.15238_15239del">
            <Expression>NG_013018.1:g.15238_15239del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001164716.1" sequenceAccession="NM_001164716" sequenceVersion="1" change="c.1811_1812del">
            <Expression>NM_001164716.1:c.1811_1812del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001158188.1" sequenceAccession="NP_001158188" sequenceVersion="1" change="p.Thr604fs">
            <Expression>NP_001158188.1:p.Thr604fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005609.4" sequenceAccession="NM_005609" sequenceVersion="4" change="c.2075_2076del" MANESelect="true">
            <Expression>NM_005609.4:c.2075_2076del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005600.1" sequenceAccession="NP_005600" sequenceVersion="1" change="p.Thr692fs">
            <Expression>NP_005600.1:p.Thr692fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1592408302" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005609.4(PYGM):c.2075_2076del (p.Thr692fs) AND Glycogen storage disease, type V" Accession="RCV000988569" Version="1">
        <ClassifiedConditionList TraitSetID="585">
          <ClassifiedCondition DB="MedGen" ID="C0017924">Glycogen storage disease, type V</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-05-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-05-28" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-01-11" MostRecentSubmission="2020-01-11">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="585" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2239" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Glycogen storage disease type 5</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GSD 5</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">McArdle disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">McArdle type glycogen storage disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscle glycogen phosphorylase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myophosphorylase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Glycogen storage disease, type V</ElementValue>
                <XRef ID="Glycogen+Storage+Disease+Type+5/3125" DB="Genetic Alliance" />
                <XRef ID="55912009" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GSD5</ElementValue>
                <XRef Type="MIM" ID="232600" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">GSD V</ElementValue>
                <XRef Type="MIM" ID="232600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6528" />
                <XRef ID="6528" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Glycogen storage disease type V (GSDV, McArdle disease) is a metabolic myopathy characterized by exercise intolerance manifested by rapid fatigue, myalgia, and cramps in exercising muscles. Symptoms are usually precipitated by isometric exercise or sustained aerobic exercise. Most individuals improve their exercise tolerance by exploiting the "second-wind" phenomenon with relief of myalgia and fatigue after a few minutes of rest. Age of onset is frequently in the first decade of life but can vary; however, diagnosis is typically delayed as myalgia and fatigability are dismissed/overlooked. Fixed muscle weakness occurs in approximately 25% of affected individuals, is more likely to involve proximal muscles, and is more common in individuals of advanced age. Approximately 50% of affected individuals have recurrent episodes of myoglobinuria that can – on occasion – eventually result in acute renal failure.</Attribute>
                <XRef ID="NBK1344" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301518</ID>
                <ID Source="BookShelf">NBK1344</ID>
              </Citation>
              <XRef ID="368" DB="Orphanet" />
              <XRef ID="C0017924" DB="MedGen" />
              <XRef ID="MONDO:0009293" DB="MONDO" />
              <XRef Type="MIM" ID="232600" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2244142" SubmissionDate="2019-10-22" DateLastUpdated="2020-01-11" DateCreated="2020-01-11">
        <ClinVarSubmissionID localKey="NC_000011.9:g.64517949_64517950delGG|OMIM:232600" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001138339" DateUpdated="2020-01-11" DateCreated="2020-01-11" Type="SCV" Version="1" SubmitterName="Mendelics" OrgID="500035" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-05-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Mendelics Assertion Criteria 2017</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/chhjzatu/mendelics_assertion_criteria_2017.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PYGM" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.64517949_64517950delGG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="232600" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MENDELICS_CLINVAR_020</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2244142" TraitType="Disease" MappingType="XRef" MappingValue="232600" MappingRef="OMIM">
        <MedGen CUI="C0017924" Name="Glycogen storage disease, type V" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

